Modulation of M2 muscarinic receptor-receptor interaction by immunoglobulin G antibodies from Chagas' disease patients

Clinical and Experimental Immunology

Volumn 164, Issue 2, 2011, Pages 170-179

  Beltrame, S P ^a   Auger, S R ^b   Bilder, C R ^c   Waldner, C I ^a   Goin, J C ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b Hospital Santojanni Buenos Aires   (Argentina)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

BRET; Chagas; IgG; M2 mAChR; Receptor receptor interaction

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; MUSCARINIC M2 RECEPTOR; RENILLA LUCIFERIN 2 MONOOXYGENASE; YELLOW FLUORESCENT PROTEIN;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; BACTERIAL PROTEINS; CHAGAS DISEASE; CHOLINERGIC AGENTS; ENERGY TRANSFER; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; LUCIFERASES, RENILLA; LUMINESCENCE; LUMINESCENT PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR CROSS-TALK; RECEPTOR, MUSCARINIC M2; RECOMBINANT FUSION PROTEINS; TRYPANOSOMA CRUZI;

EID: 79953801045     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04370.x     Document Type: Article

References (33)

1. Goin JC, Borda E, Leiros CP, Storino R, Sterin-Borda L. Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. J Auton Nerv Syst 1994; 47:45-52.
2. Goin JC, Leiros CP, Borda E, Sterin-Borda L. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J 1997; 11:77-83.
3. 2 muscarinic cholinoceptor activation by human chagasic autoantibodies: association with bradycardia. Heart 1999; 82:273-8.
4. Goin JC, Sterin-Borda L, Bilder CR etal. Functional implications of circulating muscarinic cholinergic receptor autoantibodies in chagasic patients with achalasia. Gastroenterology 1999; 117:798-805.
5. Sterin-Borda L, Goin JC, Bilder CR, Iantorno G, Hernando AC, Borda E. Interaction of human chagasic IgG with human colon muscarinic acetylcholine receptor: molecular and functional evidence. Gut 2001; 49:699-705.
6. Chiale PA, Ferrari I, Mahler E etal. Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 2001; 103:1765-71.
7. Baba A, Yoshikawa T, Fukuda Y etal. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 2004; 25:1108-15.
8. Peukert S, Fu ML, Eftekhari P etal. The frequency of occurrence of anti-cardiac receptor autoantibodies and their correlation with clinical manifestation in patients with hypertrophic cardiomyopathy. Autoimmunity 1999; 29:291-7.
9. Elies R, Ferrari I, Wallukat G etal. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease. J Immunol 1996; 157:4203-11.
10. Goin JC, Pérez Leirós C, Borda E, Sterin-Borda L. Human chagasic IgG and muscarinic cholinergic receptor interaction: pharmacological and molecular evidence. Mol Neuropharmacol 1994; 3:189-96.
11. Goin JC, Perez Leiros C, Borda E, Sterin-Borda L. Modification of cholinergic-mediated cellular transmembrane signals by the interaction of human chagasic IgG with cardiac muscarinic receptors. Neuroimmunomodulation 1994; 1:284-91.
12. 2+ currents. Cardiovasc Res 2003; 58:55-65.
13. Hernandez CC, Nascimento JH, Chaves EA etal. Autoantibodies enhance agonist action and binding to cardiac muscarinic receptors in chronic Chagas' disease. J Recept Signal Transduct Res 2008; 28:375-401.
14. Zeng FY, Wess J. Identification and molecular characterization of m3 muscarinic receptor dimers. J Biol Chem 1999; 274:19487-97.
15. Maggio R, Barbier P, Colelli A, Salvadori F, Demontis G, Corsini GU. G protein-linked receptors: pharmacological evidence for the formation of heterodimers. J Pharmacol Exp Ther 1999; 291:251-7.
16. Park PS, Wells JW. Oligomeric potential of the M2 muscarinic cholinergic receptor. J Neurochem 2004; 90:537-48.
17. Goin JC, Nathanson NM. Quantitative analysis of muscarinic acetylcholine receptor homo- and heterodimerization in live cells: regulation of receptor down-regulation by heterodimerization. J Biol Chem 2006; 281:5416-25.
18. Boyer SB, Clancy SM, Terunuma M etal. Direct interaction of GABAB receptors with M2 muscarinic receptors enhances muscarinic signaling. J Neurosci 2009; 29:15796-809.
19. Pisterzi LF, Jansma DB, Georgiou J etal. Oligomeric size of the m2 muscarinic receptor in live cells as determined by quantitative fluorescence resonance energy transfer. J Biol Chem 2010; 285:16723-38.
20. Novi F, Stanasila L, Giorgi F, Corsini GU, Cotecchia S, Maggio R. Paired activation of two components within muscarinic M3 receptor dimers is required for recruitment of beta-arrestin-1 to the plasma membrane. J Biol Chem 2005; 280:19768-76.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.
22. Mellon P, Parker V, Gluzman Y, Maniatis T. Identification of DNA sequences required for transcription of the human alpha 1-globin gene in a new SV40 host-vector system. Cell 1981; 27:279-88.
23. Cheng ZJ, Miller LJ. Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J Biol Chem 2001; 276:48040-7.
24. Xu Y, Piston DW, Johnson CH. A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. Proc Natl Acad Sci USA 1999; 96:151-6.
25. Angers S, Salahpour A, Joly E etal. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 2000; 97:3684-9.
26. Goin JC, Nathanson NM. Subtype-specific regulation of the expression and function of muscarinic acetylcholine receptors in embryonic chicken retinal cells. J Neurochem 2002; 83:964-72.
27. Leppik RA, Miller RC, Eck M, Paquet JL. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor. Mol Pharmacol 1994; 45:983-90.
28. Lee NH, el-Fakahany EE. Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem Pharmacol 1991; 42:199-205.
29. 2 muscarinic receptors in rat ventricles with anti-peptide antibodies. J Histochem Cytochem 1994; 42:337-43.
30. Leiros CP, Sterin-Borda L, Borda ES, Goin JC, Hosey MM. Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease. J Biol Chem 1997; 272:12989-93.
31. 2 acetylcholine receptor. Eur J Biochem 1998; 251:659-66.
32. Sterin-Borda L, Leiros CP, Goin JC etal. Participation of nitric oxide signaling system in the cardiac muscarinic cholinergic effect of human chagasic IgG. J Mol Cell Cardiol 1997; 29:1851-65.
33. Ribeiro AL, Gimenez LE, Hernandez CC etal. Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease. Int J Cardiol 2007; 117:59-63.